Combining a microfluidic amplification system with massive parallel sequencing is an effective method for mutation scanning, which has previously been employed for the diagnostics of familial hypercholesterolemia [26] and here was applied to BRCA1 and BRCA2 sequencing. The gene discussed is BRCA1; the disease is familial hypercholesterolemia.